Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
eo2401 (3 trials)
eo2463 (1 trial)
lenalidomide (revlimid) (1 trial)
nivolumab (opdivo) (1 trial)
rituximab (rituxan) (1 trial)
eb8018 (2 trials)
Adrenocortical Carcinoma (Phase 2)
Carcinoma (Phase 2)
Carotid Body Tumor (Phase 2)
Crohn Disease (Phase 1)
Glioblastoma (Phase 2)
Paraganglioma (Phase 2)
Pheochromocytoma (Phase 2)
Trials (7 total)
Trial APIs (6 total)